08/23/2024
3:15 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:48 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:07 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 424B5 | |
08/02/2024
4:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:29 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/16/2024
4:05 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:27 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
7:03 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:36 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:36 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:19 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:19 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
4:05 PM | Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024
4:08 PM | Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:09 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/27/2024
5:48 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:20 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:20 PM | Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:20 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:21 PM | Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:21 PM | Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:22 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:23 PM | Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
10:28 AM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:47 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:37 PM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Wei Lin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:20 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:08 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:56 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:31 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
"Doomsday indicator” flashing for the first time since the Great Depression... (Ad) It's been a bloodbath in the markets.
The seven most valuable US tech companies lost a combined $1 trillion - in a single day.
And things could get a lot worse... Click here to discover how Wall Street insiders are quietly preparing for a market crash >>> |
06/03/2024
3:40 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
3:31 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
4:11 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form S-3ASR | |
05/03/2024
6:36 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
3:30 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEF 14A | |
04/25/2024
3:35 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEFA14A | |
04/12/2024
7:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:23 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
3:57 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wei Lin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
3:24 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:43 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:45 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:45 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:50 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:10 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:21 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:04 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:48 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
3:32 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
3:52 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:53 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:54 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:54 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:55 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:30 PM | EcoR1 Capital, LLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/14/2024
8:26 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024
5:06 AM | BB BIOTECH AG (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024
4:11 PM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/09/2024
4:22 PM | COLUMN GROUP III, LP (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/08/2024
9:17 AM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:18 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:26 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
1:15 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:06 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:31 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
3:14 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:22 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:08 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:10 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:30 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:35 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here. |
12/14/2023
5:38 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144/A | |
12/14/2023
4:55 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
5:14 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
5:22 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
4:48 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
4:37 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
3:33 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
5:24 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:14 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free RVMD Stock Alerts